CORT125281 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)

NCT03335956 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Corcept Therapeutics